Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: J Glaucoma. 2017 Apr;26(4):311–314. doi: 10.1097/IJG.0000000000000370

Table 4.

Intraocular Pressure Management

Variable GDD CPC p-value

IOP
  Pre-op 27.8 ± 8.5 33.2 ± 8.6 0.0172*
  Final 16.5 ± 8.7 14.5 ± 8.5
  Reduction 11.3 ± 9.8 18.7 ± 12.0
  % Reduction* 40.7% (p < 0.0001) 56.3% (p < 0.0001)

Glaucoma Meds
  Pre-op 3.88 ± 0.98 3.57 ± 1.03 0.3906
  Final 2.56 ± 1.32 2.62 ± 1.60
  Reduction 1.31 ± 1.31 (p < 0.0001) 0.95 ± 1.72 (p=0.0194)

Tests for the difference in IOP reduction between treatment groups.

*

Test for difference in pre-operative and final IOP within the same treatment group

T-tests were used for continuous variables; a Cochran-Armitage Trend Test was used for the ordinal IOP Category variable